Detalles de la búsqueda
1.
Cardio-renal-metabolic disease in primary care setting.
Diabetes Metab Res Rev;
40(3): e3755, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38115715
2.
Myocardial Blood Flow Determination From Contrast-Free Magnetic Resonance Imaging Quantification of Coronary Sinus Flow.
J Magn Reson Imaging;
59(4): 1258-1266, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37491887
3.
The independent association of myocardial extracellular volume and myocardial blood flow with cardiac diastolic function in patients with type 2 diabetes: a prospective cross-sectional cohort study.
Cardiovasc Diabetol;
22(1): 78, 2023 03 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37004049
4.
Reduction of cardiac adipose tissue volume with short-term empagliflozin treatment in patients with type 2 diabetes: A substudy from the SIMPLE randomized clinical trial.
Diabetes Obes Metab;
25(3): 844-855, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36484428
5.
The effects of empagliflozin on measured glomerular filtration rate and estimated extracellular and plasma volumes in patients with type 2 diabetes.
Diabetes Obes Metab;
25(10): 2888-2896, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37395341
6.
Subclinical hypothyroidism in pregnancy - assessment of offspring thyroid status and mitochondrial robustness to stress.
Scand J Clin Lab Invest;
83(7): 501-508, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37942740
7.
Effects of adding exercise to usual care in patients with either hypertension, type 2 diabetes or cardiovascular disease: a systematic review with meta-analysis and trial sequential analysis.
Br J Sports Med;
57(14): 930-939, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36450440
8.
Impact of serial cardiopulmonary point-of-care ultrasound exams in patients with acute dyspnoea: a randomised, controlled trial.
Emerg Med J;
40(10): 700-707, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37595984
9.
Interventions involving own treatment choice for people living with coexisting severe mental illness and type 1 or 2 diabetes: A scoping review.
Diabet Med;
38(9): e14626, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34152639
10.
Metabolic improvement with short-term, glucagon-like peptide-1 receptor agonist treatment does not improve cardiac diastolic dysfunction in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial.
Diabetes Obes Metab;
23(10): 2374-2384, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34189832
11.
Prevalence of urinary incontinence among women with diabetes in the Lolland-Falster Health Study, Denmark.
Neurourol Urodyn;
40(3): 855-867, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33645842
12.
Distinct non-ischemic myocardial late gadolinium enhancement lesions in patients with type 2 diabetes.
Cardiovasc Diabetol;
19(1): 184, 2020 10 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33092588
13.
Fibroblast growth factor-23 is associated with imaging markers of diabetic cardiomyopathy and anti-diabetic therapeutics.
Cardiovasc Diabetol;
19(1): 158, 2020 09 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-32998751
14.
Hypoglycaemia and its management in primary care setting.
Diabetes Metab Res Rev;
36(8): e3332, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32343474
15.
Mitochondrial energetics and contents evaluated by flow cytometry in human maternal and umbilical cord blood.
Scand J Clin Lab Invest;
80(5): 351-359, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32468866
16.
Beneficial impact of intensified multifactorial intervention on risk of stroke: outcome of 21 years of follow-up in the randomised Steno-2 Study.
Diabetologia;
62(9): 1575-1580, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31154479
17.
A cost analysis of intensified vs conventional multifactorial therapy in individuals with type 2 diabetes: a post hoc analysis of the Steno-2 study.
Diabetologia;
62(1): 147-155, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30293113
18.
Reduced risk of heart failure with intensified multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: 21 years of follow-up in the randomised Steno-2 study.
Diabetologia;
61(8): 1724-1733, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29850922
19.
Intensified multifactorial intervention in type 2 diabetics with microalbuminuria leads to long-term renal benefits.
Kidney Int;
91(4): 982-988, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28187983
20.
Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial.
Diabetologia;
59(11): 2298-2307, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27531506